[go: up one dir, main page]

GB9706046D0 - Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent - Google Patents

Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent

Info

Publication number
GB9706046D0
GB9706046D0 GBGB9706046.1A GB9706046A GB9706046D0 GB 9706046 D0 GB9706046 D0 GB 9706046D0 GB 9706046 A GB9706046 A GB 9706046A GB 9706046 D0 GB9706046 D0 GB 9706046D0
Authority
GB
United Kingdom
Prior art keywords
crystallization
solvent
reverse transcriptase
transcriptase inhibitor
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9706046.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9706046.1A priority Critical patent/GB9706046D0/en
Publication of GB9706046D0 publication Critical patent/GB9706046D0/en
Priority to KR1019997006985A priority patent/KR100573192B1/en
Priority to EA199900720A priority patent/EA001805B1/en
Priority to CA002279198A priority patent/CA2279198C/en
Priority to PCT/US1998/001999 priority patent/WO1998033782A1/en
Priority to SK1055-99A priority patent/SK284935B6/en
Priority to CZ20040883A priority patent/CZ304186B6/en
Priority to JP53319098A priority patent/JP3418626B2/en
Priority to AU62632/98A priority patent/AU738545C/en
Priority to CZ0276599A priority patent/CZ297535B6/en
Priority to EEP199900341A priority patent/EE03827B1/en
Priority to IL13071598A priority patent/IL130715A/en
Priority to CN98802171A priority patent/CN1073991C/en
Priority to EP98904853A priority patent/EP0975609B1/en
Priority to AT98904853T priority patent/ATE486065T1/en
Priority to DE69841972T priority patent/DE69841972D1/en
Priority to NZ336510A priority patent/NZ336510A/en
Priority to HU0001313A priority patent/HU229087B1/en
Priority to PL334478A priority patent/PL197740B1/en
Priority to CNB011227095A priority patent/CN1191242C/en
Priority to NO19993779A priority patent/NO320128B1/en
Priority to JP2002163198A priority patent/JP2003040874A/en
Priority to JP2010202879A priority patent/JP5295190B2/en
Priority to JP2013089216A priority patent/JP2013139484A/en
Priority to JP2015146631A priority patent/JP6126172B2/en
Priority to JP2017002745A priority patent/JP2017061575A/en
Pending legal-status Critical Current

Links

GBGB9706046.1A 1997-02-05 1997-03-24 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent Pending GB9706046D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB9706046.1A GB9706046D0 (en) 1997-03-24 1997-03-24 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
CNB011227095A CN1191242C (en) 1997-02-05 1998-02-02 Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1,4-dihydro-2H-3,1-benzoxazine-2-ketone
CN98802171A CN1073991C (en) 1997-02-05 1998-02-02 Process for crystallization of reverse transcriptase inhibitor using anti-solvent
AT98904853T ATE486065T1 (en) 1997-02-05 1998-02-02 METHOD FOR CRYSTALLIZING A REVERS TRANSCRIPTASE INHIBITOR USING AN ANTI-SOLVENT
CA002279198A CA2279198C (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
PCT/US1998/001999 WO1998033782A1 (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
SK1055-99A SK284935B6 (en) 1997-02-05 1998-02-02 Form I of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl- 1,4-dihydro-2H-3,1-benzoxazin-2-one and method for its crystallization
CZ20040883A CZ304186B6 (en) 1997-02-05 1998-02-02 Crystalline form of I inhibitor based on benzoxazine and process for preparing thereof
JP53319098A JP3418626B2 (en) 1997-02-05 1998-02-02 Crystallization method of reverse transcriptase inhibitor using antisolvent
AU62632/98A AU738545C (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
CZ0276599A CZ297535B6 (en) 1997-02-05 1998-02-02 Benzoxazinone based inhibitor crystallization method
EEP199900341A EE03827B1 (en) 1997-02-05 1998-02-02 A method for crystallizing a transcriptase rotary inhibitor using an anti-solvent
IL13071598A IL130715A (en) 1997-02-05 1998-02-02 Form i of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoro-methyl-1,4-dihydro-2h-3,1-benzoxazin-2-one and a process for preparing the crystalline form of said compound
KR1019997006985A KR100573192B1 (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent and crystal forms of the same
EP98904853A EP0975609B1 (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
EA199900720A EA001805B1 (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
DE69841972T DE69841972D1 (en) 1997-02-05 1998-02-02 METHOD FOR CRYSTALLIZING A REVERSTRANSCRIPTASE INHIBITOR WHERE AN ANTI SOLVENT IS USED
NZ336510A NZ336510A (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
HU0001313A HU229087B1 (en) 1997-02-05 1998-02-02 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
PL334478A PL197740B1 (en) 1997-02-05 1998-02-02 Method of crystallising and inhibitor of reverse hiv transcriptase using an antisolvent
NO19993779A NO320128B1 (en) 1997-02-05 1999-08-04 Process for crystallizing a reverse transcriptase inhibitor using an antisolvent
JP2002163198A JP2003040874A (en) 1997-02-05 2002-06-04 Method for crystallizing reverse transcriptase inhibitor using a non-solvent
JP2010202879A JP5295190B2 (en) 1997-02-05 2010-09-10 Method for crystallization of reverse transcriptase inhibitor using reverse solvent
JP2013089216A JP2013139484A (en) 1997-02-05 2013-04-22 Method for crystallization of reverse transcriptase inhibitor using anti-solvent
JP2015146631A JP6126172B2 (en) 1997-02-05 2015-07-24 Method for crystallization of reverse transcriptase inhibitor using reverse solvent
JP2017002745A JP2017061575A (en) 1997-02-05 2017-01-11 Process for the crystallization of reverse transcriptase inhibitor using anti-solvent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706046.1A GB9706046D0 (en) 1997-03-24 1997-03-24 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent

Publications (1)

Publication Number Publication Date
GB9706046D0 true GB9706046D0 (en) 1997-05-14

Family

ID=10809754

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9706046.1A Pending GB9706046D0 (en) 1997-02-05 1997-03-24 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent

Country Status (1)

Country Link
GB (1) GB9706046D0 (en)

Similar Documents

Publication Publication Date Title
HK1016585A1 (en) Retroviral protease inhibiting compounds
NO954299L (en) Device for lining a well
IL121538A0 (en) A process for the removal of vapor
HUP0101797A3 (en) Tamper-indicating article for reusable substrates
GB9711451D0 (en) A process for the treatment of effluent streams
PT937068E (en) PROCESS FOR THE CRYSTALLIZATION OF LOSARTAN
DK89294A (en) Process for crystallization of iodamidol
NO975770D0 (en) Process for the preparation of a refractory repair compound
IL121900A0 (en) A method for the purification of immunoglobulins
IL120942A0 (en) A process for the epoxidation of alkenes
HK1028619A1 (en) Process for the preparation of a polyamide-polyurethane micro-blend
PL330764A1 (en) Crystalline for of a pharmaceutic agent
ID21998A (en) PROCESS FOR THE MAKING OF A CONTINUOUS ALKIL 5-FORMILVALERATE COMPOUND
HUP9904518A3 (en) Process for the crystallization of polyethylene naphthalate prepolymers
HUP9903806A3 (en) A process for the biotransformation of colchicionid compounds into the corresponding 3-glycosyl derivatives
NO20062796L (en) Process for the preparation of a dihydroxyamino compound
ZA945055B (en) A method for the partial metallization of a substrate
HUP0001926A3 (en) A process for the crystallization of lactitol
GB9706046D0 (en) Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
GB9709348D0 (en) Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
HUP0004840A3 (en) A process for the biotransformation of colchicone compounds into the corresponding 3-glycosyl derivatives
GR3036063T3 (en) A process for the manufacture of imidazodiazepine derivatives
ZA972099B (en) Process for the preparation of a dessert
IL122553A0 (en) A continuous process for the dinitration of aromatic substrates
GB9714048D0 (en) A process for the elecctrochemical treatment of concrete